Impact of a physician-oriented intervention on follow-up in colorectal cancer screening
- PMID: 15020170
- DOI: 10.1016/j.ypmed.2003.11.010
Impact of a physician-oriented intervention on follow-up in colorectal cancer screening
Abstract
Background: Complete diagnostic evaluation or CDE (i.e., colonoscopy or combined flexible sigmoidoscopy plus barium enema X-ray) is often not performed for persons with an abnormal screening fecal occult blood test (FOBT+) result.
Method: This study evaluated the impact of a reminder-feedback and educational outreach intervention on primary care practice CDE recommendation and performance rates. Four hundred seventy primary care physicians (PCPs) in 318 practices participated in the study. Patients were mailed an FOBT kit annually as part of a screening program. Practices were randomly assigned to a Control Group (N = 198) or an Intervention Group (N = 120). During an 18-month pre-randomization period and a 9-month post-randomization period, 2992 screening FOBT+ patients were identified. Intervention practices received the screening program and the intervention. Control practices received only the screening program. Study outcomes were baseline-adjusted CDE recommendation and performance rates.
Results: At baseline, about two-thirds of FOBT+ patients received a CDE recommendation, and about half had a CDE performed. At endpoint, CDE recommendation and performance rates were both significantly higher for the Intervention as compared to the Control practices (OR = 2.28; 95% CI: 1.37, 3.78, and OR = 1.63; 95% CI: 1.06, 2.50, respectively).
Conclusions: The reminder-feedback plus educational outreach intervention significantly increased CDE recommendation and performance.
Similar articles
-
Complete diagnostic evaluation in colorectal cancer screening: research design and baseline findings.Prev Med. 2001 Oct;33(4):249-60. doi: 10.1006/pmed.2001.0878. Prev Med. 2001. PMID: 11570828 Clinical Trial.
-
Physician intention to recommend complete diagnostic evaluation in colorectal cancer screening.Cancer Epidemiol Biomarkers Prev. 1999 Jul;8(7):587-93. Cancer Epidemiol Biomarkers Prev. 1999. PMID: 10428195
-
Measuring complete diagnostic evaluation in colorectal cancer screening.Cancer Detect Prev. 2001;25(2):174-82. Cancer Detect Prev. 2001. PMID: 11341353
-
Adherence with colorectal cancer screening guidelines: a review.Prev Med. 2004 May;38(5):536-50. doi: 10.1016/j.ypmed.2003.12.011. Prev Med. 2004. PMID: 15066356 Review.
-
Screening for colorectal cancer.Tech Coloproctol. 2004 Nov;8 Suppl 1:s10-3. doi: 10.1007/s10151-004-0098-9. Tech Coloproctol. 2004. PMID: 15655587 Review.
Cited by
-
Knowledge of symptoms and diagnostic possibilities of cancer diseases.Arch Med Sci. 2011 Apr;7(2):304-9. doi: 10.5114/aoms.2011.22082. Epub 2011 May 17. Arch Med Sci. 2011. PMID: 22291771 Free PMC article.
-
Barriers of and facilitators to physician recommendation of colorectal cancer screening.J Gen Intern Med. 2007 Dec;22(12):1681-8. doi: 10.1007/s11606-007-0396-9. Epub 2007 Oct 16. J Gen Intern Med. 2007. PMID: 17939007 Free PMC article.
-
Results of nurse navigator follow-up after positive colorectal cancer screening test: a randomized trial.J Am Board Fam Med. 2014 Nov-Dec;27(6):789-95. doi: 10.3122/jabfm.2014.06.140125. J Am Board Fam Med. 2014. PMID: 25381076 Free PMC article. Clinical Trial.
-
Audit and feedback: effects on professional practice.Cochrane Database Syst Rev. 2025 Mar 25;3(3):CD000259. doi: 10.1002/14651858.CD000259.pub4. Cochrane Database Syst Rev. 2025. PMID: 40130784
-
A tool for evaluating the potential for cost-effective outcomes measurement.Int J Gen Med. 2012;5:365-72. doi: 10.2147/IJGM.S30546. Epub 2012 Apr 18. Int J Gen Med. 2012. PMID: 22573943 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical